Cochlear Limited
Cochlear Limited
- P/E ratio
- 68.08
Your view on COH.AX
Overview
What the company does, where it operates, and who runs it.
About Cochlear Limited
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Diggory William Howitt
- Headquarters
- 1 University Avenue, Sydney, NSW, AU
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Diggory William Howitt
- Headquarters
- 1 University Avenue, Sydney, NSW, AU
Globally, Cochlear Limited specializes in the development and provision of implantable auditory solutions for both children and adults. The company's diverse offerings include advanced cochlear implant systems, upgrades for sound processors, bone conduction devices, and a wide array of accessories and other related items.
Established in 1981, its global operations are directed from its headquarters in Sydney, Australia.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Cochlear Limited from FRC's valuation model, read against the market price. COH.AX last traded at AUD 124.86, 68.1× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Cochlear Limited. Starting points for Cochlear Limited: P/E 68.1, EPS AUD 2.25, beta 0.26 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Cochlear Limited. Cochlear Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Cochlear Limited. Trailing twelve-month EPS for Cochlear Limited stands at AUD 2.25. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Earnings Estimate
| EPS | Current QtrSep 2025 | Next QtrDec 2025 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | AUD 0.00 | AUD 3.15 | AUD 5.23 | AUD 5.72 |
| Low estimate | AUD 0.00 | AUD 3.15 | AUD 5.04 | AUD 5.10 |
| High estimate | AUD 0.00 | AUD 3.15 | AUD 5.61 | AUD 6.29 |
| No. of analysts | 0 | 1 | 13 | 14 |
| Year-ago EPS | AUD 2.15 | AUD 2.41 | AUD 2.251 | — |
| Growth | −100.0% | +30.7% | — | — |
1Year-ago EPS includes one-time items; growth not shown.
Revenue Estimate
| Revenue | Current QtrSep 2025 | Next QtrDec 2025 | Current YearFY Jun 2027 | Next YearFY Jun 2028 |
|---|---|---|---|---|
| Avg. estimate | AUD 1.22B | AUD 1.22B | AUD 2.39B | AUD 2.52B |
| Low estimate | AUD 1.22B | AUD 1.22B | AUD 2.26B | AUD 2.38B |
| High estimate | AUD 1.22B | AUD 1.22B | AUD 2.46B | AUD 2.62B |
| No. of analysts | 6 | 1 | 16 | 16 |
| Year-ago revenue | AUD 892.60M | AUD 1.06B | AUD 2.33B | — |
| Growth | +36.7% | +14.3% | +2.2% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Cochlear Limited. Cochlear Limited has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AT1.AXAtomo Diagnostics Limited | Healthcare | Medical - Devices | — | ||
| AVR.AXAnteris Technologies Ltd | Healthcare | Medical - Devices | — | ||
| CBL.AXControl Bionics Limited | Healthcare | Medical - Devices | — | ||
| EBR.AXEBR Systems, Inc. | Healthcare | Medical - Devices | — | ||
| OSL.AXOncoSil Medical Ltd | Healthcare | Medical - Devices | — | ||
| PNV.AXPolyNovo Limited | Healthcare | Medical - Devices | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| CBLLCeriBell, Inc. | Healthcare | NASDAQ | $995.3M | ||
| CERSCerus Corporation | Healthcare | NASDAQ | $391.8M | ||
| CGHCCapital Group Holdings, Inc. | Healthcare | OTC | $9,220 | ||
| CHEOFCochlear Limited | Healthcare | OTC | $8.9B | ||
| CHEOYCochlear Limited | Healthcare | OTC | $9.2B | ||
| CHYPFHealth Logic Interactive Inc. | Healthcare | OTC | $165,839 | ||
| CLLKFBICO Group AB (publ) | Healthcare | OTC | $123.3M | ||
| CLPTClearPoint Neuro, Inc. | Healthcare | NASDAQ | $247.1M | ||
| CLVSFCellaVision AB (publ) | Healthcare | OTC | $378.0M | ||
| CMP.AXCompumedics Limited | Healthcare | ASX | — | ||
| CNMDCONMED Corporation | Healthcare | NYSE | $1.4B | ||
| Ticker | Fund | Fund assets | % of the fund |
|---|---|---|---|
| VXUSVanguard Total International Stock ETF | $163.2B in assets | 0.02% | |
| VEAVanguard FTSE Developed Markets ETF | $231.6B in assets | 0.02% | |
| IEFAiShares Core MSCI EAFE ETF | $188.8B in assets | 0.03% | |
| SCZiShares MSCI EAFE Small-Cap ETF | $12.6B in assets | 0.20% | |
| WSRD.TOWealthsimple Developed Markets ex North America Socially Responsible Index ETF | $926M in assets | 0.43% | |
| FNDCSchwab Fundamental International Small Equity ETF | $3.0B in assets | 0.13% | |
| GSWOGoldman Sachs ActiveBeta World Equity ETF | $1.7B in assets | 0.11% | |
| XHC.TOiShares Global Healthcare Index ETF (CAD-Hedged) | $631M in assets | 0.08% | |
Largest holders first, then the funds most concentrated in COH.AX.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Cochlear Limited. Coverage tracks Cochlear Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Cochlear Limited.